Christopher R. Cline, CFO: Travere Therapeutics TVTX Sell · Filed 24/04/12

Trade details

Type: Insider sale
Amount: $363.96
Shares · price: 54 sh · $6.74 a share
Held after: 70,849 sh
Stock: Travere Therapeutics TVTX
Person: Christopher R. ClineCFO
Trade date: 24/04/11
Filed: 24/04/12
Days to filing: 1 days

Sold 0.1% of holdings

Share of holding sold: 0.1%

Travere Therapeutics trades, last 26 weeks

What else happened in Travere Therapeutics around then

Filed or reported within 30 days of the trade day · 24/03/12~24/05/11

Christopher R. Cline's recent trades

Christopher R. ClineCFO
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$3.3M
50,508 sh
$3.3M
Filed 09/15
Traded 09/15
Christopher R. ClineCFO
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$101.7K
2,181 sh
$101.7K
Filed 05/06
Traded 05/05
Christopher R. ClineCFO
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$13.6K
310 sh
$13.6K
Filed 05/06
Traded 05/06
Christopher R. ClineCFO
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$13.6K
310 sh
$13.6K
Filed 05/06
Traded 05/06
Christopher R. ClineCFO
Planned saleTravere Therapeutics
Planned sale
Travere Therapeutics
TVTX
$101.7K
2,181 sh
$101.7K
Filed 05/05
Traded 05/05